Your browser doesn't support javascript.
loading
Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?
Jakobs, Kai; Rauch, Ursula.
Affiliation
  • Jakobs K; Department of Cardiology, Campus Benjamin Franklin Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Rauch U; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
Eur Heart J ; 43(37): 3575-3577, 2022 10 07.
Article in En | MEDLINE | ID: mdl-35393607
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Fibrinolytic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Heart J Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Fibrinolytic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Heart J Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom